Summit Global Investments’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,952
Closed -$520K 617
2023
Q3
$520K Sell
7,952
-7,771
-49% -$489K 0.03% 333
2023
Q2
$914K Buy
+15,723
New +$992K 0.06% 247
2022
Q2
Sell
-9,929
Closed -$900K 547
2022
Q1
$900K Sell
9,929
-1,771
-15% -$145K 0.07% 252
2021
Q4
$1.07M Sell
11,700
-8,800
-43% -$754K 0.07% 226
2021
Q3
$1.66M Sell
20,500
-900
-4% -$75.6K 0.12% 147
2021
Q2
$2M Buy
+21,400
New +$2.07M 0.12% 136

Other funds holding NARI

Summit Global Investments's NARI Position: Q4 2023 in Review

Summit Global Investments sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2023, closing a stake of 7,952 shares — an estimated $520K sold.

Summit Global Investments first reported a position in NARI in Q2 2021 and held it in 6 quarters. The position peaked at $2M in Q2 2021. 252 funds tracked by Wall St. Rank hold NARI as of Q4 2023.

  • Summit Global Investments reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Summit Global Investments sold 7,952 Inari Medical, Inc. Common Stock shares in Q4 2023, an estimated $520K.
  • Summit Global Investments first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Summit Global Investments's Inari Medical, Inc. Common Stock position peaked at $2M in Q2 2021.
  • 252 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2023.

Based on Summit Global Investments's 13F filing for Q4 2023, filed 6 Feb 2024.